Lisa Mullett

Lisa Mullett is Senior Vice President, General Manager of Sumitomo Pharma Canada, Inc. Prior to this role, Lisa served as Senior Vice President of Commercial Development and Strategic Partnerships for Sumitomo Pharma America, as well as Chief Commercial Officer for Sunovion Pharmaceuticals Inc., from 2022 to 2023. Lisa has served as the General Manager of Sumitomo Pharma Canada, Inc., since 2019.

As Chief Commercial Officer of Sunovion Pharmaceuticals Inc. she also served as a member of the Executive Leadership Team and Board of Directors for Sumitomo Pharma. In this role, Lisa guided commercial strategy for the portfolio of marketed products and led the commercialization efforts for Sunovion’s future therapeutics.

From 2017 to 2019, Lisa served as the Executive Director, New Product Planning and Senior Director, Commercial Strategy & Planning, Chief of Staff to the Chief Commercial Officer at Sunovion Pharmaceuticals Inc. corporate headquarters in the U.S. From 2008 to 2017, and Lisa held roles of increasing responsibility as the Director of Hospital Products, Director of Marketing and Director of Central Nervous System (CNS) Business Unit in Canada. Earlier in her career, she served in several senior roles at GSK including Group Product Manager, Hospital Business Manager, District Sales Manager and Senior Manager, Reimbursement Strategy.

In addition, Lisa sits on the Board of Directors of Innovative Medicines Canada since 2020 and has served as Treasurer since 2022.

Lisa holds a B.A. in Administration and Commercial Studies from the University of Western Ontario.